TRV Maintained by Mizuho -- Price Target Raised to $348

Josh Brown of Ritholtz Wealth Management highlights the profitability of financial stocks, including Interactive Brokers (IBKR) and Travelers (TRV). IBKR reported strong Q2 earnings with 28% revenue growth and 39% net income increase. The company is positioned to gain market share in tax-aware long-short strategies. TRV showed resilience with flat performance despite a sector downturn, reporting strong Q2 results and consistent growth.

Travelers Companies (TRV) has added Anthony Jabbour to its board and key committees. The move is noted for potential investment implications, though the article does not provide specific financial details or analysis. Simply Wall St emphasizes that the information is not financial advice and does not constitute a recommendation to buy or sell any stock.

Zacks reports that by July 24, 135 S&P 500 companies have posted Q2 2026 results, with total earnings up 67.8% year over year and revenue up 12.6%, while 87.4% beat EPS and 79.3% beat revenue estimates. It highlights three Dow blue chips with favorable Zacks Ranks: 3M (MMM), Travelers (TRV), and UnitedHealth (UNH), citing 2026 guidance and estimate revisions.

On July 24, the Dow rose 235.60 points (0.46%) to 51,947.25, while the Nasdaq fell 161.87 points (0.64%) to 24,975.82 for a third straight session. The semiconductor selloff followed Intel’s post-earnings drop of 7.89% to $92.32, dragging chip peers including Micron and AMD. Oil prices eased on Middle East peace-talk hopes.

Travelers Companies (TRV) has risen more than 30% in 2026 to record highs, supported by strong Q2 results and demand for defensive insurers. At least six analysts downgraded TRV this month, including Goldman Sachs to sell and BMO to market perform, citing valuation and limited upside. TRV trades near 12x forward earnings and 2.7x tangible book value.

Travelers Companies (TRV) shares rose about 2.8% to a 52-week high of $386.77, after its Q2 2026 results on July 17. The insurer reported core income of $2.2 billion, or $10.04 per diluted share, nearly double consensus, helped by lower catastrophe losses and higher net investment income. Analysts raised price targets, including Mizuho to $343, and Travelers returned over $1.5 billion via buybacks and dividends.